Additionally, to determine if miR-940 levels vary in benign prostatic hyperplasia (BPH) and metastatic prostate tumors (Mets), we performed in situ hybridization and immunohistochemistry and quantified the staining intensities of miR-940 as well as MIEN1 in these tissues. The gene discussed is MIEN1; the disease is prostate neoplasm.